"Welcome to Woolfson Eye Institute in Chattanooga! Woolfson Eye Institute was founded in 1996 by LASIK pioneer Dr. Jonathan Woolfson. In the last 20 years, the team at Woolfson Eye Institute has performed over 100,000 LASIK procedures, and over 300 eye doctors have entrusted Dr. Woolfson with their own LASIK surgery. While Woolfson Eye Institute is headquartered in Atlanta, Dr. Woolfson travels around the Southeast and offers LASIK surgery across nine locations in Georgia, Tennessee, and North Carolina. This means you don’t have to drive to Atlanta for LASIK surgery with Dr. Woolfson, as he personally offers LASIK surgery in the Chattanooga area. Call for your appointment!"

During the past decade, Woolfson Eye conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Woolfson Eye" are "Corneal Ulcer" (2 trials) and "Keratitis" (2 trials). Many other conditions were trialed in "Woolfson Eye" in a lesser frequency.

Most popular intervention types in "Woolfson Eye" are "Combination Product" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "PXL Platinum 330 system + Riboflavin 0.25% TE Solution" (1 trials), "Sham CXL + Artificial Tears" (1 trials), "Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution" (1 trials) and "Standard of Care Therapy + Sham CXL + Artificial Tears" (1 trials). Other intervention names were less common.

The vast majority of trials in "Woolfson Eye" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Woolfson Eye". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Woolfson Eye, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Woolfson Eye, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".